Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-12

Clinical Trial Update: Venetoclax-Decitabine in Untreated Elderly/Unfit AML [NA]

View source ↗

Summary

This clinical trial update indicates recruitment for a venetoclax and decitabine regimen in untreated elderly or unfit adults with acute myeloid leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dacogen (decitabine)
  • Venclexta (venetoclax)

Snippet

Sponsor: The Second Hospital of Hebei Medical University | Conditions: AML, Adult | NA | Status: RECRUITING